[1]Rosi F, Carlucci F, Marinello E, et al.Ecto-5’-nucleotidase in B-cell chronic lymphocytic leukemia [ J].Biomed Pharmacother, 2002, 56(2):100-104.
[2]Resta R, Yamashita Y, Thompson LF. Ecto-enzyme and signaling functions of lymphocyte CD73[J]. Immunol Rev,1998,161:95-109.
[3]Beavis PA, Stagg J, Darcy PK, et al. CD73: a potent suppressor of antitumor immune responses[J]. Trends Immunol, 2012, 33(5): 231-237.
[4]Li Q, Qi LJ, Guo ZK, et al. CD73+ adipose-derived mesenchymal stem cells possess higher potential to differentiate into cardiomyocytes in vitro[J]. J Mol Histol, 2013, 44(4):411-422.
[5]Bavaresco L, Bernardi A, Braganhol E, et al. The role of ecto-5’-nucleotidase/CD73 in glioma cell line proliferation[J]. Mol Cell Bio Chem, 2008, 319(1-2):61-68.
[6]Allard B, Turcotte M, Stagg J. CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growth. J Biomed Biotechnol, 2012, 85156.
[7]Park JS,Kim HY, Kim HW, et al.Increased caveolin-1,a cause for the declined adipogenic potential of senescent human mesenehymal stem cells[J].Mech Ageing,2005, 126(5):551-559.
[8]Andrade CM, Lopez PL, Noronha BT, et al. Ecto-5’-nucleotidase/CD73 knockdown increases cell migration and mRNA level of collagen I in a hepatic stellate cell line[J]. Cell Tissue Res, 2011, 344(2):279-286.
[9]Gao ZhW, Wang HP, Lin F, et al. CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity[J]. BMC Cancer, 2017, 17:135-136.[10]Zhi X, Wang Y, Yu J, et al. Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer[J]. IUBMB Life, 2012,64(11):911-920.
[11]Bynoe MS, Viret C, Yan A, et al. Adenosine receptor signaling: a key to opening the blood-brain door[J]. Fluids Barriers CNS, 2015, 20(12):1-12.
[12]Colgan SP, Eltzschig HK, Eckle T, et al. Physiological roles for ecto-5’-nucleotidase (CD73)[J]. Purinergic Signal, 2006,2(2):351-360.
[13] Eltzschig HK, Sitkovsky MV, Robson SC. Purinergic signaling during inflammation[J]. N Engl J Med, 2012, 367(24):2322-2333.
[14]Ohta A. A metabolic immune checkpoint: adenosine in tumor microenvironment[J]. Front Immunol, 2016,109(7):1-11.
[15]B?nner F, Borg N, Jacoby C, et al. Ecto-5’-nucleotidase on immune cells protects from adverse cardiac remodeling[J]. Circ Res, 2013, 113(3):301-312.
|